Main Article Content
Abstract
Systemic lupus erythematosus (SLE) patients have multi-organ involvement related to their chronic inflammatory, autoimmune disease. Calcinosis can be clinical manifestations of SLE. Tissue calcinosis is reported in approximately 17% patients and myocarditis in 20-55% patients. Thus, both manifestations are not unusual in SLE. Tachypnea, tachycardia, pericardial effusion, and wheezing are often present and can be misleading in SLE patient.1,2 Calcinosis is less common in SLE, sometimes
it is found as an incidental radiological finding. Calcification in SLE maybe periarticular, within joints or muscles, or in the subcutis (calcinosis universalis).1 Calcinosis is classified into four subsets: dystrophic, metastatic, idiopathic, or calciphylaxis/iatrogenic. When calcinosis cutis is isolated to a small area in extremities and joints, it is called calcinosis circumscripta; whereas its diffuse form, refers to calcinosis universalis, affects subcutaneous and fibrous structures of muscles and tendons. The pathophysiology of this condition is unknown and no effective therapy is currently available.3,4,5 Systemic lupus erythematosus can involve the myocardium, pericardium, cardiac valves,
and coronary arteries. Myocarditis in SLE is not likely to produce major regional wall motion abnormalities but may contribute to global left ventricular dysfunction.7,8
We report a young woman with SLE who developed calcinosis and myocarditis.
it is found as an incidental radiological finding. Calcification in SLE maybe periarticular, within joints or muscles, or in the subcutis (calcinosis universalis).1 Calcinosis is classified into four subsets: dystrophic, metastatic, idiopathic, or calciphylaxis/iatrogenic. When calcinosis cutis is isolated to a small area in extremities and joints, it is called calcinosis circumscripta; whereas its diffuse form, refers to calcinosis universalis, affects subcutaneous and fibrous structures of muscles and tendons. The pathophysiology of this condition is unknown and no effective therapy is currently available.3,4,5 Systemic lupus erythematosus can involve the myocardium, pericardium, cardiac valves,
and coronary arteries. Myocarditis in SLE is not likely to produce major regional wall motion abnormalities but may contribute to global left ventricular dysfunction.7,8
We report a young woman with SLE who developed calcinosis and myocarditis.
Article Details
How to Cite
Dewi, S., & Wachjudi, R. G. (2018). Calcinosis and myocarditis in systemic lupus erythematosus patient. Indonesian Journal of Rheumatology, 1(2). https://doi.org/10.37275/ijr.v2i1.28
References
- Wallace DJ, Hahn BH, editors. Dubois’ lupus erythematosus. 7th ed.
- Philadelphia: Lipincot Williams & Wilkins; 2007. p. 621-1223.
- Tsokos GC, Gordon C, Smolen JS, editors. Systemic lupus
- erythematosus: a companion to rheumatology. 1st ed. Philadelphia:
- Mosby Elsevier; 2007. p. 498-508.
- Tristano AG, Villarroel JL, Rodriguez MA, Millan A. Calcinosis cutis
- universalis in a patient with systemic lupus erythematosus: case
- report. Clin Rheumatol 2005;25:70-4.
- Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in
- rheumatic diseases. Arthritis & Rheumatism 2005;34:805-12.
- Ogretmen Z, Akay A, Bicakci C, Bicakci HC. Calcinosis cutis
- universalis. J Eur Acad Dermatol Venereol 2002;16(6):621-4.
- Li HS, Ligons DL, Rose NR. Genetic complexity of autoimmune
- myocarditis. Autoimmun Rev 2008;7(3):168-73.
- Woo SI, Hwang GS, Kang SJ, Park JS, Lee YS, Lee YH, and Tahk SJ.
- Lupus myocarditis presenting as acute congestive heart failure: a case
- report. J Korean Med Sci 2009;24:176-8.
- Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R,
- et al. EULAR Recommendations for monitoring systemic lupus
- erythematosus patients in clinical practice and in observational
- studies. Ann Rheum Dis 2009;10:1136-72.